1 / 1

Mortality Data From the BASKET LATE Trial and PREMIER Registry

Mortality Data From the BASKET LATE Trial and PREMIER Registry. BASKET LATE Trial: Cardiac Death in DES vs. BMS (%) p=0.09. PREMIER Registry Data: All Cause Death According to Minimum 30 day thienopyridine Therapy Duration (%) p<0.0001. % patients. % patients.

ginger-mcdowell
Download Presentation

Mortality Data From the BASKET LATE Trial and PREMIER Registry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mortality Data From the BASKET LATE Trial and PREMIER Registry BASKET LATE Trial: Cardiac Death in DES vs. BMS (%) p=0.09 PREMIER Registry Data: All Cause Death According to Minimum 30 day thienopyridine Therapy Duration (%) p<0.0001 % patients % patients • In the BASKET LATE Trial, cardiac death trended higher in the DES group than in the BMS group during the year following clopidogrel discontinuation (1.2% vs. 0%, p=0.09). • Data from the PREMIER registry looked exclusively at AMI patients who received DES and suggested that patients who discontinued thienopyridine therapy early - within 30 days in this instance - were significantly more likely to die over the next 11 months (p<0.0001).

More Related